In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Advances and unmet needs in chronic thromboembolic pulmonary hypertension around the globe
Session

Congress : ESC Congress 2019

Topic : Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure - Treatment

  • Session type : Symposium
  • Date : 02 September 2019
  • Time : 16:40 - 17:50

4 presentations in this session

Diagnostic dilemma: is it acute pulmonary embolism or chronic thromboembolic pulmonary hypertension?

Congress : ESC Congress 2019

  • Session : Advances and unmet needs in chronic thromboembolic pulmonary hypertension around the globe
  • Speaker : D Gopalan (London,GB)

The chronic thromboembolic pulmonary hypertension registry

Congress : ESC Congress 2019

  • Session : Advances and unmet needs in chronic thromboembolic pulmonary hypertension around the globe
  • Speaker : M Delcroix (Leuven,BE)

Indications and results of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Congress : ESC Congress 2019

  • Session : Advances and unmet needs in chronic thromboembolic pulmonary hypertension around the globe
  • Speaker : E Fadel (,FR)

Emerging experience with pulmonary balloon angioplasty for chronic thromboembolic pulmonary hypertension

Congress : ESC Congress 2019

  • Session : Advances and unmet needs in chronic thromboembolic pulmonary hypertension around the globe
  • Speaker : H Matsubara (Okayama,JP)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are